As the generic pharmaceuticals division of Novartis and the second biggest generic drug enterprise in the world, Sandoz mainly offers a broad portfolio of high-quality affordable medicines. Since it settled down in Zhongshan in 2010, the enterprise has made steady growth with an output value of 0.5 billion yuan in 2010. It is one of the Top 100 Strong Foreign Enterprise and the key cultivating enterprise in Torch development Zone.